Company information:
Emed Pharma Group Limited (No: 09697610)
Address: ALEXANDRA HOUSE, 43 ALEXANDRA STREET, NOTTINGHAM, NG5 1AY, ENGLAND
Status: Active
Incorporated: 22-Jul-2015
Accounts Next Due: 30-Sep-2024
Next Confirmation Statement Due: 08-Apr-2024
Industry Class: 62090 - Other information technology service activities
Current Director: PER ULRIK BERGSTROM ( DOB: Mar-1958 From: Aug-2015 )
Current Director: MAHESH KUMAR JAYANARAYAN ( DOB: Jan-1952 From: Jul-2015 )
Current Director: STANLEY GEORGE SHEPHERD ( DOB: Apr-1945 From: Jul-2018 )
Resigned Director: CHARLES JOHN JAMES EASMON ( DOB: Sep-1961 From: May-2016 To: Sep-2017 )
Resigned Director: THOMAS LENNART JANSSON ( From: May-2018 To: Jul-2018 )
Resigned Director: KENNETH JOHN MADILL ( DOB: Apr-1957 From: Jul-2018 To: Jan-2022 )
Resigned Director: KENNETH JOHN MADILL ( From: May-2016 To: Mar-2017 )
Resigned Director: ASIF MUKHTAR ( DOB: Mar-1974 From: May-2018 To: May-2018 )
Resigned Director: EUGEN RAZVAN POPA ( DOB: Jul-1976 From: Jun-2018 To: Aug-2023 )
Resigned Director: NICHOLAS SULLIVAN ( DOB: Jan-1961 From: May-2016 To: Sep-2017 )
Resigned Director: DOMINIC ANDREW WHITE ( DOB: Mar-1972 From: Oct-2016 To: Mar-2017 )
Persons of Significant Control:
Bergstrom Cmg Associates Limited, 157 Oxford Gardens, London, W10 6NE, England: Ownership of shares – More than 25% but not more than 50%, Ownership of voting rights - More than 25% but not more than 50% (Notified: 2016-04-06, Ceased: 2019-12-31)
Mrs Gunilla Bergstrom, Alexandra House 43 Alexandra Street, Nottingham, NG5 1AY, England: Ownership of shares – More than 25% but not more than 50% (Notified: 2019-12-31)
Company Accounts Summary (£)
Item | 16 | 17 | 18 | 19 | 20 | 22 | 23 | Chart |
---|---|---|---|---|---|---|---|---|
Fixed assets | 1,209,102 | 1,395,311 | 1,517,015 | 1,643,538 | 1,651,338 | 1,661,048 | 1,661,048 | 1209102.0,1395311.0,1517015.0,1643538.0,1651338.0,1661048.0,1661048.0 |
Fixed assets / Intangible assets | 1,170,102 | 1,356,311 | 1,515,926 | 1,643,538 | 1,651,338 | 1170102.0,1356311.0,1515926.0,1643538.0,1651338.0,0.0,0.0 | ||
Fixed assets / Investments, fixed assets | 39,000 | 39,000 | 1,089 | 39000.0,39000.0,1089.0,0.0,0.0,0.0,0.0 | ||||
Current assets | 96,378 | 169,030 | 38,471 | 42,297 | 5,850 | 3,931 | 4,283 | 96378.0,169030.0,38471.0,42297.0,5850.0,3931.0,4283.0 |
Current assets / Debtors | 94,719 | 167,147 | 37,795 | 41,388 | 5,666 | 94719.0,167147.0,37795.0,41388.0,5666.0,0.0,0.0 | ||
Current assets / Debtors / Trade debtors / trade receivables | 4,655 | 7,188 | 8,750 | 4655.0,7188.0,0.0,8750.0,0.0,0.0,0.0 | ||||
Current assets / Cash at bank and on hand | 1,659 | 1,883 | 676 | 909 | 184 | 1659.0,1883.0,676.0,909.0,184.0,0.0,0.0 | ||
Net current assets (liabilities) | 60,340 | 72,133 | 5,168 | -98,776 | -110,724 | -165,931 | -177,756 | 60340.0,72133.0,5168.0,-98776.0,-110724.0,-165931.0,-177756.0 |
Total assets less current liabilities | 1,269,442 | 1,467,444 | 1,522,183 | 1,544,762 | 1,540,614 | 1,495,117 | 1,483,292 | 1269442.0,1467444.0,1522183.0,1544762.0,1540614.0,1495117.0,1483292.0 |
Net assets (liabilities) | 338,763 | 902,326 | 1,469,079 | 1,480,672 | 1,488,167 | 338763.0,902326.0,1469079.0,1480672.0,1488167.0,0.0,0.0 | ||
Equity / share capital and reserves | 338,763 | 902,326 | 1,469,079 | 1,480,672 | 1,488,167 | 1,495,117 | 1,483,292 | 338763.0,902326.0,1469079.0,1480672.0,1488167.0,1495117.0,1483292.0 |